Waldstreicher Joanne
SEC insider (Form 3/4/5 filer). CIK 0001962413. Director at Structure Therapeutics Inc. (GPCR) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Waldstreicher Joanne has filed insider reports for
- Structure Therapeutics Inc. (GPCR): Director
- BECTON DICKINSON & CO (BDX): Director
Waldstreicher Joanne
CIK: 0001962413
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 17, 2026GPCR
Structure Therapeutics Inc.
AwardDirectShare Option (right to buy)
39.5K shares- - Jan 27, 2026BDX
BECTON DICKINSON & CO
AwardDirect1.1K shares- - Jun 23, 2025GPCR
Structure Therapeutics Inc.
AwardDirectShare Option (right to buy)
51.8K shares- - Jan 28, 2025BDX
BECTON DICKINSON & CO
AwardDirect930 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 |  GPCR Structure Therapeutics Inc. | Award Share Option (right to buy) | 39,453 | - | - | Direct |
| Jan 27, 2026 |  BDX BECTON DICKINSON & CO | Award | 1,098 | - | $0 | Direct |
| Jun 23, 2025 | GPCR Structure Therapeutics Inc. | Award Share Option (right to buy) | 51,804 | - | - | Direct |
| Jan 28, 2025 | BDX BECTON DICKINSON & CO | Award | 930 | - | $0 | Direct |
1-4 of 4 transactions